Questions about how much you will pay? We are here to help.

A live specialist can help you understand your insurance coverage, monthly co-pay, and other support available to help you afford YEZTUGO®.

Call 1-800-226-20561-800-226-2056 or enroll online at www.GileadAdvancingAccess.com.

The amount a person pays for YEZTUGO depends on their individual circumstances and insurance plan. Below is a guide for what you can expect to pay.

Click on what best describes your coverage situation:


Typically, a person taking YEZTUGO pays between $0 and $5 for oral and $0 and $5 for the injections, during the initiation year. For the continuation year, a person typically pays between $0 and $5 for the injections.

The initiation year list price for YEZTUGO consists of an oral component of $2,351.50 and an injectable component of $28,218. The continuation year list price consisting of injections is $28,218. The list price is not typically the price a patient pays.

If eligible, the Advancing Access® program could help you lower your out-of-pocket costs to as little as $0. Co-Pay Savings program is available for eligible, commercially insured individuals only. Additional restrictions may apply. Subject to change; for full terms and conditions, visit GileadAdvancingAccess.com/copay-coupon-card. This is not health insurance.

Call 1-800-226-2056 to talk to a specialist or enroll online at www.GileadAdvancingAccess.com.

Medicare covers YEZTUGO without cost sharing, including deductibles or copayments, for people with Medicare who are eligible. Contact your Medicare plan provider, healthcare provider, or pharmacy, or click here for more information.

The initiation year list price for YEZTUGO consists of an oral component of $2,351.50 and an injectable component of $28,218. The continuation year list price consisting of injections is $28,218. The list price is not typically the price a patient pays.

States can impose cost sharing (copayments, coinsurance, deductibles, etc.) on most Medicaid-covered benefits, including drugs. Cost sharing for most services is limited to nominal amounts. Some state Medicaid programs offer lower co-pays or eliminate co-pays altogether for certain populations.

For more information about co-pays in your state, or whether you qualify for Medicaid, click here.

The initiation year list price for YEZTUGO consists of an oral component of $2,351.50 and an injectable component of $28,218. The continuation year list price consisting of injections is $28,218. The list price is not typically the price a patient pays..

Support programs are available to help with insurance coverage and/or paying for prescription medicine.

Call the Advancing Access® Patient Support Program at 1-800-226-2056 to talk to a specialist who can help with a benefits investigation, or go to www.GileadAdvancingAccess.com to enroll online. You may be able to receive the medication free of charge.

The initiation year list price for YEZTUGO consists of an oral component of $2,351.50 and an injectable component of $28,218. The continuation year list price consisting of injections is $28,218. The list price is not typically the price a patient pays.

Call the Advancing Access Patient Support Program at 1-800-226-2056 1-800-226-2056 to talk to a specialist who can help you. The specialist can find programs to help you with insurance coverage and financial support to pay for YEZTUGO.

The initiation year list price for YEZTUGO consists of an oral component of $2,351.50 and an injectable component of $28,218. The continuation year list price consisting of injections is $28,218. The list price is not typically the price a patient pays.

Derived from data sourced from Symphony Health (Patient Transaction Data) (June 2025 - December 26, 2025, accessed January 2026).

List price is also known as wholesale acquisition cost or WAC. WAC is listed as of January 1, 2026, for a 12 month supply of YEZTUGO.

U.S. Department of Health and Human Services. Medicaid and CHIP Overview for Assisters. https://marketplace.cms.gov/technical-assistance-resources/fast-facts-medicaid-chip.pdf. Updated 2018.

The information on this site is intended for audiences in the United States only. The content on this site may not apply to non-U.S. audiences as regularly control, legal requirements and/or medical practices may vary in other countries.

BIKTARVY, the BIKTARVY Logo, DESCOVY, the DESCOVY Logo, EPCLUSA, the EPCLUSA Logo, TRODELVY, the TRODELVY Logo, YEZTUGO, the YEZTUGO Logo, GILEAD, the GILEAD Logo, ADVANCING ACCESS, and SUPPORT PATH are trademarks of Gilead Sciences, Inc., or its related companies. All other marks referenced herein are the property of their respective owners.

©2026 Gilead Sciences. Inc. All rights reserved. US-PTFC-0069 01/26